Dare Bioscience Inc

DARE

Company Profile

  • Business description

    Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women’s health.

  • Contact

    3655 Nobel Drive
    Suite 260
    San DiegoCA92122
    USA

    T: +1 858 926-7655

    E: [email protected]

    https://www.darebioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    23

Stocks News & Analysis

stocks

Chart of the Week: AI proving a threat to company moats

The latest insights on AI from our equity research team.
stocks

ASX coal miners will benefit from higher prices

Middle East conflict pushes coal prices higher.
stocks

Nvidia earnings: Another stellar quarter with no signs of a slowdown

We think Nvidia stock is moderately undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,690.7021.10-0.24%
CAC 407,845.43124.45-1.56%
DAX 4022,980.71521.54-2.22%
Dow JONES (US)46,199.62793.64-1.69%
FTSE 10010,121.77183.52-1.78%
HKSE25,500.58524.84-2.02%
NASDAQ22,152.42327.11-1.46%
Nikkei 22553,372.531,866.87-3.38%
NZX 50 Index13,051.61130.62-0.99%
S&P 5006,626.8289.27-1.33%
S&P/ASX 2008,497.807.60-0.09%
SSE Composite Index4,006.5556.43-1.39%

Market Movers